...
首页> 外文期刊>International journal of psychophysiology: official journal of the International Organization of Psychophysiology >Cholinergic deficiency in Alzheimer's and Parkinson's disease: evaluation with pupillometry.
【24h】

Cholinergic deficiency in Alzheimer's and Parkinson's disease: evaluation with pupillometry.

机译:阿尔茨海默氏病和帕金森氏病的胆碱能缺乏症:用瞳孔测定法评估。

获取原文
获取原文并翻译 | 示例

摘要

The aim of the study was to evaluate the cholinergic deficiency in Alzheimer's (AD) and Parkinson's disease (PD). For this purpose, pupil size changes and mobility were assessed using a fast-video pupillometer (263 frames/s). Twenty-three (23) patients with probable AD and twenty-two (22) patients with PD (eleven with cognitive impairment and eleven without) entered the study. A full record of the pupil's reaction to light was registered. From this data ten (10) parameters were measured and reported. Comparison of those parameters in both group of subjects followed. Patients with probable AD had abnormal pupillary function compared to healthy ageing. All the Pupil Light Reflex (PLR) variables significantly differed between the two groups (p<0.005) except the Baseline Pupil Diameter after 2-min dark adaptation (D1) and the Minimum Pupil Diameter (D2). Maximum Constriction Acceleration (ACmax) was the best predictor in classifying a subject as normal or as an AD with a perfect classification ability (AUC=1, p<0.001). ACmax and Maximum Constriction Velocity (VCmax) were significantly lower in PD patients without and with coexisting cognitive impairment compared to normal subjects (p<0.001). Patients with cognitive impairment had significantly lower levels of ACmax, VCmax and amplitude (AMP=D1-D2) than patients with no cognitive deficits. ACmax and secondarily VCmax were the best predictors in classifying a subject as normal or as a PD patient with or without cognitive impairment. Cognitive and memory impairment, which reflects a cholinergic deficit, may be a crucial pathogenetic factor for the decrease in the aforementioned pupillometric parameters. VCmax and ACmax can be considered as the most sensitive indicators of this cholinergic deficiency.
机译:该研究的目的是评估阿尔茨海默氏病(AD)和帕金森氏病(PD)的胆碱能缺乏症。为此,使用快速视频瞳孔计(263帧/秒)评估瞳孔大小变化和活动度。二十三(23)例可能患有AD的患者和二十二(22)例患有PD的患者(其中11例患有认知障碍,十一例没有认知障碍)。记录了学生对光反应的完整记录。根据该数据,测量并报告了十(10)个参数。随后在两组受试者中比较那些参数。与健康老龄化相比,可能患有AD的患者瞳孔功能异常。除2分钟暗适应(D1)后的基线瞳孔直径(D1)和最小瞳孔直径(D2)外,两组的所有瞳孔光反射(PLR)变量均存在显着差异(p <0.005)。最大收缩加速(ACmax)是将受试者分类为正常或具有完美分类能力的AD(AUC = 1,p <0.001)的最佳预测指标。与正常受试者相比,无认知障碍和并存认知障碍的PD患者的ACmax和最大收缩速度(VCmax)显着降低(p <0.001)。认知障碍患者的ACmax,VCmax和振幅水平(AMP = D1-D2)明显低于无认知缺陷的患者。 ACmax和VCmax是将受试者分类为正常或PD患者(有或没有认知障碍)的最佳预测指标。反映胆碱能缺陷的认知和记忆障碍可能是导致上述瞳孔测量参数降低的重要致病因素。 VCmax和ACmax可被视为这种胆碱能缺乏症的最敏感指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号